pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,889 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: approval×type: pdufa×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›COMPLETEDphase readoutNCT06401928: Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis

    Sponsor: The National Brain Mapping Laboratory (NBML). Phase: NA. Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06693765: A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Renal Impairment, End-stage Kidney Disease, Healthy Participants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04266665: Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

    Sponsor: Georgia Tsaousi. Phase: PHASE4. Conditions: Brain Tumor, Metabolic Disturbance, Inflammatory Response, Oxygen Deficiency

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06221267: A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area

    Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: . Conditions: Migraine

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03703167: Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07536867: Comparison of Serratus Posterior Superior Intercostal Plane Block and Rhomboid Intercostal Block in Patients Undergoing Breast Cancer Surgery

    Sponsor: Antalya City Hospital. Phase: NA. Conditions: Breast Cancer, Lymph Node Dissection, Postoperative Pain, Mastectomy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07408167: AI Models in Clinical Pathology Diagnosis: A Multicenter RCT

    Sponsor: Nanfang Hospital, Southern Medical University. Phase: NA. Conditions: Pathology Foundation Model

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07347600: A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

    Sponsor: Hoffmann-La Roche. Phase: . Conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05008900: Timing of Post-prostatectomy PSMA Imaging

    Sponsor: University Health Network, Toronto. Phase: PHASE2. Conditions: Prostate Cancer, Prostatectomy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02863107: Young-Onset Colorectal Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Colon Adenocarcinoma, Colorectal Carcinoma, Rectal Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07015892: Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial

    Sponsor: Instituto de Investigación Biomédica de Salamanca. Phase: PHASE3. Conditions: Small Cell Lung Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07099092: Causal Mechanisms of Odor-Guided Behavior in Humans

    Sponsor: National Institute on Drug Abuse (NIDA). Phase: EARLY_PHASE1. Conditions: Normal Physiology

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05689671: Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

    Sponsor: Nikolaj Frost MD. Phase: PHASE4. Conditions: Non-Small Cell Lung Cancer Metastatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06481644: Asia Pediatric Intensive Care Epidemiology and Outcomes Study

    Sponsor: KK Women's and Children's Hospital. Phase: . Conditions: Pediatrics, Intensive Care Unit, Critical Illness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07563634: Long-term Safety and Efficacy of Adjunctive Brivaracetam in Chinese Patients With Uncontrolled Focal Epilepsy

    Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Phase: PHASE3. Conditions: Epilepsy, Focal

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07277309: Promoting Recovery After Brain Injury Using Focused Ultrasound

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Consciousness Disorders, Disorders of Consciousness Due to Severe Brain Injury

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07625709: EFFECT OF TRANEXAMIC ACID ON PERIOPERATIVE BLOOD LOSS IN REAMED INTRAMEDULLARY NAILING OF DIAPHYSEAL FEMORAL AND TIBIAL FRACTURES: A PROSPECTIVE COMPARATIVE STUDY

    Sponsor: Kathmandu University School of Medical Sciences. Phase: NA. Conditions: Blood Loss, Postoperative, Blood Loss, Surgical, Femoral Fracture, Tibial Fracture

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07361809: The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes Zoster

    Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Pain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07476599: The OB-WELL Project, a Randomized Controlled Trial of an Internet-Based Self-Help System for Psychological Support in Obesity

    Sponsor: Catholic University of the Sacred Heart. Phase: NA. Conditions: Obesity (BMI > 35)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05989399: Evaluation of Circulating Neutrophils in Antisynthetase Syndrome

    Sponsor: Central Hospital, Nancy, France. Phase: . Conditions: Antisynthetase Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07450599: A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.

    Sponsor: Bayer. Phase: PHASE2. Conditions: High-Risk Localized Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06694363: New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Activated PI3K Delta Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06140693: A Comparison of Affective Responses During Continuous and Interval Exercise

    Sponsor: University of Stirling. Phase: NA. Conditions: Health Behavior

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06164106: Feasibility Trial of a Single Session of Crisis Response Planning for Youth at High Risk for Suicide

    Sponsor: Ohio State University. Phase: NA. Conditions: Suicide Prevention

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07395206: Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders

    Sponsor: Charite University, Berlin, Germany. Phase: NA. Conditions: Psychosis, Psychotic Disorders, Primary Psychotic Disorders, Schizophrenia Spectrum Disorders, Schizophrenia, Schizoaffective Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05902104: CGM-Assisted Management of PN

    Sponsor: Boston Children's Hospital. Phase: . Conditions: Intestinal Failure, Hypoglycemia, Hyperglycemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07580014: Choroidal and Retinal Features in PACD and POAG on OCT and OCTA

    Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: . Conditions: Glaucoma, OCTA, Choroid

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02965716: Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT02738606: Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Metastatic Malignant Neoplasm in the Lung, Recurrent Colorectal Carcinoma, Resectable Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05193084: Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure

    Sponsor: Heartfelt Technologies. Phase: . Conditions: Heart Failure

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07410533: Analysis of Factors Associated With the Efficacy of 595-nm Pulsed Dye Laser Treatment for Rosacea

    Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: NA. Conditions: Pulsed Dye Laser, Rosacea

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07569133: Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease

    Sponsor: Ho-Won Lee. Phase: NA. Conditions: Parkinson's Disease, Depression

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07333781: Effects of Communication Training for Mental Health Occupational Therapy Interns

    Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Communication

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07364981: Gaze Contingent Attentional Reinforcement in Major Depressive Disorder

    Sponsor: Tel Aviv University. Phase: NA. Conditions: Major Depressive Disorder (MDD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04712565: Hard and Soft Tissue Maintenance Around Implants With a Sloped Configuration

    Sponsor: Medical University of Graz. Phase: NA. Conditions: Tooth Loss

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01047865: Type 1 Diabetes Recurrence in Pancreas Transplants

    Sponsor: University of Miami. Phase: . Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04864067: No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer

    Sponsor: Servicio de Salud Metropolitano Sur Oriente. Phase: PHASE2. Conditions: Rectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06613100: Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

    Sponsor: Amgen. Phase: PHASE1. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06934200: Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels

    Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Food Hypersensitivity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05935800: The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates

    Sponsor: Methodist Health System. Phase: . Conditions: Frailty, Sarcopenia, COVID-19

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07638800: Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults

    Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Trial Participants

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05955300: Nutrition and Movement to Improve Quality of Life With Knee Osteoarthritis

    Sponsor: St. Pölten University of Applied Sciences. Phase: NA. Conditions: Osteo Arthritis Knee

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07609836: Caudal Dexamethasone - Bupivacaine in Neonates

    Sponsor: Ain Shams University. Phase: NA. Conditions: We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03262636: Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

    Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Brain Tumor, Primary, Brain Tumor, Recurrent

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07349836: Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

    Sponsor: Xinqiao Hospital of Chongqing. Phase: EARLY_PHASE1. Conditions: EBV-associated Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07583836: DELAYED VERSUS EARLY SURGICAL DECOMPRESSION FOR TRAUMATIC SPINAL CORD INJURY

    Sponsor: Fauji Foundation Hospital. Phase: . Conditions: Traumatic Spinal Cord Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07367971: Drug-Drug Interaction Study of ABP-671 in Gout Patients

    Sponsor: Atom Therapeutics Co., Ltd. Phase: PHASE1. Conditions: Gout Chronic, Gout, DDI (Drug-Drug Interaction)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07380334: A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

    Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06777134: Relationship Between Pelvic Floor Dysfunctions and Lower Limb Strength and Activation in MS Patients

    Sponsor: Berivan Beril Kılıç. Phase: . Conditions: Multiple Sclerosis, Pelvic Floor Dysfunction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07568509: Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

    Sponsor: Massachusetts General Hospital. Phase: EARLY_PHASE1. Conditions: Arginine Vasopressin Deficiency, Oxytocin Deficiency, Pediatric Disease, Hypopituitarism

    full page →ctgov ↗
    ← prev
    page 63 of 98
    next →